New use of an old drug: inhibition of breast cancer stem cells by benztropine mesylate

SUPPLEMENTARY METHODS
Ligand-based target prediction using SPiDER 1.0
For ligand-based target prediction of benztropine mesylate, we used the self-organizing map-based prediction of drug equivalence relationships (SPiDER version 1.0; modlab-cadd.ethz.ch/software/spider/) ((1) Briefly, benztropine mesylate was preprocessed with the Molecular Operating Environment (MOE; Chemical Computing Group, Montreal, Canada; Version 2011.10) "wash" function (protonate bases, deprotonate acids, add hydrogens). Subsequently, the molecule was described in terms of its pharmacophoric correlation vector (CATS2) (2) and physicochemical properties (MOE2D). Using these descriptor vectors, the molecule was co-clustered with known drug-like compounds (COBRA database, v12.6, inSili.com) (3) and targets inferred statistically according to the distance to known ligands in chemical space, rationalized by a background distribution of intertarget drug-drug similarities. The two acquired prediction scores (CATS2 and MOE2D) were averaged to yield a consensus score. This consensus score was again evaluated statistically by converting it into a conservative p value according to a background database of prediction scores achieved by random drug-like molecules. These reported p values indicate the confidence in a prediction by putting them into perspective according to target scores that are acquired trough random chemical similarity. Full technical details can be found in the original publication (1). 
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